BioMed Research International

T Lymphocyte Plasticity in Autoimmunity and Cancer


Publishing date
07 Aug 2015
Status
Published
Submission deadline
20 Mar 2015

1Université Bourgogne Franche-Comté, Dijon, France

2Tbilisi State Medical University, Tbilisi, Georgia

3University Hospital of Dijon, Dijon, France

4University of Arizona, Arizona, USA


T Lymphocyte Plasticity in Autoimmunity and Cancer

Description

T lymphocytes are essential for the development and regulation of adaptive immune responses. Upon engagement of their specific antigen receptor and in presence of appropriate costimulatory signals and specific cytokines, naïve CD4+ and CD8+ T cells differentiate into different effector or suppressor subsets exhibiting distinct phenotypic characteristics and functions. These specialized T lymphocyte subsets may be distinguished by a dedicated transcription factor and cytokine expression profile. Although some of these polarized T-cell subpopulations are typically stable and do not transdifferentiate into other subsets, evidence has been provided that others, such as T helper 1 (Th1), T helper 17 (Th17), or regulatory T (Treg) cells, are characterized by variable degrees of plasticity as demonstrated by their capability to be “reprogrammed” into different suppressor or proinflammatory effector T cells.

We invite investigators to contribute original research articles as well as review articles that seek to address the mechanisms and significance of altered T lymphocyte (CD4+ T helper or CD8+ cytotoxic T lymphocytes) differentiation and function in the pathogenesis of immune-mediated disorders and cancer. A particular interest will be given to papers exploring or discussing the concept of T lymphocyte stability/reprogramming and its relevance in pathological conditions with a specific emphasis on FoxP3+ Treg and Th17 or Th1 cells.

Potential topics include, but are not limited to:

  • Altered frequencies and functions of T lymphocyte subsets (Th1, Th2, Th9, Th17, Th22, Tfh, Tr1, and Treg) in the pathogenesis of autoimmune diseases and cancer
  • Importance and significance of T lymphocyte plasticity in human diseases
  • Molecular and cellular mechanisms responsible for T cell lineage commitment, polarization, and possible reprogramming of T helper (Th1, Th17, Treg, etc.) cells in autoimmunity and cancer
  • Treg or Th17 cell stability versus reprogramming in autoimmunity and cancer: controversies and potential therapeutic implications

Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 540750
  • - Editorial

T Lymphocyte Plasticity in Autoimmunity and Cancer

Nona Janikashvili | Tinatin Chikovani | ... | Nicolas Larmonier
  • Special Issue
  • - Volume 2015
  • - Article ID 184574
  • - Review Article

T Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein, α1-Antitrypsin

Boris M. Baranovski | Gabriella S. Freixo-Lima | ... | Peleg Rider
  • Special Issue
  • - Volume 2015
  • - Article ID 314620
  • - Review Article

Th17 Cell Plasticity and Functions in Cancer Immunity

Leslie Guéry | Stéphanie Hugues
  • Special Issue
  • - Volume 2015
  • - Article ID 521957
  • - Review Article

Functional and Phenotypic Plasticity of CD4+ T Cell Subsets

Tiffany Caza | Steve Landas
  • Special Issue
  • - Volume 2015
  • - Article ID 430943
  • - Research Article

LAP TGF-Beta Subset of CD4+CD25+CD127 Treg Cells is Increased and Overexpresses LAP TGF-Beta in Lung Adenocarcinoma Patients

Lorenzo Islas-Vazquez | Heriberto Prado-Garcia | ... | Jose Sullivan Lopez-Gonzalez
  • Special Issue
  • - Volume 2015
  • - Article ID 504638
  • - Review Article

T Lymphocyte Dynamics in Inflammatory Bowel Diseases: Role of the Microbiome

C. B. Larmonier | K. W. Shehab | ... | P. R. Kiela
  • Special Issue
  • - Volume 2015
  • - Article ID 327470
  • - Review Article

T Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer: An Overview

Ekaterina A. Ivanova | Alexander N. Orekhov
  • Special Issue
  • - Volume 2015
  • - Article ID 137893
  • - Research Article

Vitamin A Impairs the Reprogramming of Tregs into IL-17-Producing Cells during Intestinal Inflammation

Gabriela Tejón | Valeria Manríquez | ... | Mario Rosemblatt
  • Special Issue
  • - Volume 2015
  • - Article ID 891236
  • - Research Article

T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1

Malika Trad | Alexandrine Gautheron | ... | Bernard Bonnotte
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.